Search by Drug Name or NDC
NDC 43063-0046-19 Chlordiazepoxide Hydrochloride 25 mg/1 Details
Chlordiazepoxide Hydrochloride 25 mg/1
Chlordiazepoxide Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Chlordiazepoxide is used to relieve anxiety and to control agitation caused by alcohol withdrawal. Chlordiazepoxide is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 43063-0046-19Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Chlordiazepoxide
Product Information
| NDC | 43063-0046 |
|---|---|
| Product ID | 43063-046_febc49d0-cb09-438c-e053-6394a90aacd2 |
| Associated GPIs | 57100020100115 |
| GCN Sequence Number | 003735 |
| GCN Sequence Number Description | chlordiazepoxide HCl CAPSULE 25 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14032 |
| HICL Sequence Number | 001610 |
| HICL Sequence Number Description | CHLORDIAZEPOXIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Chlordiazepoxide Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlordiazepoxide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA084769 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43063-0046-19 (43063004619)
| NDC Package Code | 43063-046-19 |
|---|---|
| Billing NDC | 43063004619 |
| Package | 19 CAPSULE in 1 BOTTLE, PLASTIC (43063-046-19) |
| Marketing Start Date | 2010-12-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |